CIK: 0001274403 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 10, 2022
Total Value ($000): $771,381 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS, INC. | 1,312,872 | $295,304 | 38.3% | $131.00 | — | COM | 48576A100 |
| — | EQRX, INC. | 36,335,375 | $179,860 | 23.3% | $6.82 | — | COM | 26886C107 |
| DNLI | DENALI THERAPEUTICS, INC. | 3,668,749 | $112,594 | 14.6% | $26.20 | +24.1% | COM | 24823R105 |
| ERAS | ERASCA, INC. | 11,055,554 | $86,233 | 11.2% | $17.12 | -53.0% | COM | 29479A108 |
| — | VERVE THERAPEUTICS, INC. | 2,008,809 | $69,003 | 8.9% | $36.87 | — | COM | 92539P101 |
| — | REVOLUTION HEALTHCARE ACQUISITION CORP. | 1,357,237 | $13,342 | 1.7% | $9.77 | — | COM | 76155Y108 |
| — | SINGULAR GENOMICS SYSTEMS, INC. | 3,798,926 | $9,497 | 1.2% | $11.56 | — | COM | 82933R100 |
| — | UNITY BIOTECHNOLOGY, INC. | 10,048,181 | $3,970 | 0.5% | $0.40 | — | COM | 91381U200 |
| — | METACRINE, INC. | 2,940,503 | $1,426 | 0.2% | $0.61 | — | COM | 59101E103 |
| — | RUBIUS THERAPEUTICS, INC. | 349,908 | $152 | 0.0% | $16.08 | — | COM | 78116T103 |